TY - JOUR
T1 - Frailty and access to kidney transplantation
AU - Haugen, Christine E.
AU - Chu, Nadia M.
AU - Ying, Hao
AU - Warsame, Fatima
AU - Holscher, Courtenay M.
AU - Desai, Niraj M.
AU - Jones, Miranda R.
AU - Norman, Silas P.
AU - Brennan, Daniel C.
AU - Garonzik-Wang, Jacqueline
AU - Walston, Jeremy D.
AU - Bingaman, Adam W.
AU - Segev, Dorry L.
AU - McAdams-DeMarco, Mara
N1 - Funding Information:
C.E.H.,C.M.H., F.W.,N.M.D., M.R.J., S.P.N., J.G.-W., J.D.W.,D.L.S., andM.M.-D. contributed to the conception and design. C.E.H., H.Y., N.M.C, S.P.N., D.C.B., D.L.S., and M.M.-D. contributed to the acquisition of data or analysis and interpretation of the data. C.E.H., C.M.H., H.Y., F.W., N.M.D., N.M.C., K.R.J., M.R.J., S.P.N., D.C.B., J.G.-W., J.D.W., D.L.S., and M.M.-D. contributed to drafting the article or revising it critically for important intellectual content. C.E.H., C.M.H., H.Y., F.W., N.M.D., N.M.C., M.R.J., S.P.N., D.C.B., J.G.-W., J.D.W.,D.L.S.,andM.M.-D.approvedthefinal versiontobepublished and are accountable for all aspects of the work. Funding for this study was provided by the National Institute of Diabetes and Digestive and Kidney Disease and the National Institute of Aging: grant numbers T32DK007732 (to C.E.H.), F32AG053025 (Principal Investigator: C.E.H.), F32DK109662 (Principal Investigator: C.M.H.), K23DK115908 01 (Principal Investigator: J.G.-W.), K24DK101828 (Principal Investigator: D.L.S.), R01AG055781 (Principal Investigator: M.M.-D.), R01DK114074 (Principal Investigator: M.M.-D.), and K01AG043501 (Principal Investigator: M.M.-D.).
Funding Information:
Funding for this study was provided by the National Institute of Diabetes and Digestive and Kidney Disease and the National Institute of Aging: grant numbers T32DK007732 (to C.E.H.), F32AG053025 (Principal Investigator: C.E.H.), F32DK109662 (Principal Investigator: C.M.H.), K23DK115908 01 (Principal Investigator: J.G.-W.), K24DK101828 (Principal Investigator: D.L.S.), R01AG055781 (Principal Investigator: M.M.-D.), R01DK114074 (Principal Investigator: M.M.-D.), and K01AG043501 (Principal Investigator: M.M.-D.).
Publisher Copyright:
© 2019 by the American Society of Nephrology.
PY - 2019/4/5
Y1 - 2019/4/5
N2 - Background and objectives Frailty, a syndrome distinct from comorbidity and disability, is clinically manifested as a decreased resistance to stressors and is present in up to 35% of patient with ESKD. It is associated with falls, hospitalizations,poor cognitive function, andmortality.Also, frailty is associatedwithpooroutcomes afterkidney transplant, including delirium and mortality. Frailty is likely also associated with decreased access to kidney transplantation, given its association with poor outcomes on dialysis and post-transplant. Yet, clinicians have difficulty identifyingwhich patients are frail; therefore,we sought to quantify if frail kidney transplant candidates had similar access to kidney transplantation as nonfrail candidates. Design, setting, participants, & measurements We studied 7078 kidney transplant candidates (2009-2018) in a three-center prospective cohort study of frailty. Fried frailty (unintentional weight loss, grip strength, walking speed, exhaustion, andactivity level)wasmeasuredatoutpatient kidney transplant evaluation.We estimatedtime to listing andtransplant rate by frailty statususingCoxproportional hazards andPoisson regression, adjusting for demographic and health factors. Results The mean age was 54 years (SD 13; range, 18-89), 40% were women, 34% were black, and 21% were frail. Frail participants were almost half as likely to be listed for kidney transplantation (hazard ratio, 0.62; 95% confidence interval, 0.56 to 0.69; P<0.001) compared with nonfrail participants, independent of age and other demographic factors. Furthermore, frail candidates were transplanted 32% less frequently than nonfrail candidates (incidence rate ratio, 0.68; 95% confidence interval, 0.58 to 0.81; P<0.001). Conclusions Frailty is associated with lower chance of listing and lower rate of transplant, and is a potentially modifiable risk factor.
AB - Background and objectives Frailty, a syndrome distinct from comorbidity and disability, is clinically manifested as a decreased resistance to stressors and is present in up to 35% of patient with ESKD. It is associated with falls, hospitalizations,poor cognitive function, andmortality.Also, frailty is associatedwithpooroutcomes afterkidney transplant, including delirium and mortality. Frailty is likely also associated with decreased access to kidney transplantation, given its association with poor outcomes on dialysis and post-transplant. Yet, clinicians have difficulty identifyingwhich patients are frail; therefore,we sought to quantify if frail kidney transplant candidates had similar access to kidney transplantation as nonfrail candidates. Design, setting, participants, & measurements We studied 7078 kidney transplant candidates (2009-2018) in a three-center prospective cohort study of frailty. Fried frailty (unintentional weight loss, grip strength, walking speed, exhaustion, andactivity level)wasmeasuredatoutpatient kidney transplant evaluation.We estimatedtime to listing andtransplant rate by frailty statususingCoxproportional hazards andPoisson regression, adjusting for demographic and health factors. Results The mean age was 54 years (SD 13; range, 18-89), 40% were women, 34% were black, and 21% were frail. Frail participants were almost half as likely to be listed for kidney transplantation (hazard ratio, 0.62; 95% confidence interval, 0.56 to 0.69; P<0.001) compared with nonfrail participants, independent of age and other demographic factors. Furthermore, frail candidates were transplanted 32% less frequently than nonfrail candidates (incidence rate ratio, 0.68; 95% confidence interval, 0.58 to 0.81; P<0.001). Conclusions Frailty is associated with lower chance of listing and lower rate of transplant, and is a potentially modifiable risk factor.
UR - http://www.scopus.com/inward/record.url?scp=85064472208&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064472208&partnerID=8YFLogxK
U2 - 10.2215/CJN.12921118
DO - 10.2215/CJN.12921118
M3 - Article
C2 - 30890577
AN - SCOPUS:85064472208
SN - 1555-9041
VL - 14
SP - 576
EP - 582
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 4
ER -